Mwangi wa Mutahi

Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine

Robert Aslanian, Mwangi wa Mutahi, Neng‐Yang Shih et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 33 citations · Full text

Medicinal Chemistry, Biochemistry, Functional Selectivity +6

Identification of a novel, orally bioavailable histamine H3 receptor antagonist based on the 4-benzyl-(1H-imidazol-4-yl) template

Robert Aslanian, Mwangi wa Mutahi, Neng-Yang Shih et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 27 citations · Full text

Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists

Michael Berlin, Pauline C. Ting, Wayne Vaccaro et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 16 citations · Full text

Biochemistry, Cyp450 Inhibition, Medicine +5

4- [(1H - imidazol - 4 - YL) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptor

Robert Aslanian, Joan E. Brown, N.‐Y. SHIH et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 14 citations · Full text

Histamine H3 Receptor, Biochemistry, Medicine +5